alphaveMANGALAM₹34.88

Mangalam Drugs And Organics Limited

₹ CrorePeersBIOFILCHEM LASA VINEETLAB ORTINGLOBE KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹55.2 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	104.2	133.6	115.7	115.7
+ Other Intangibles	20.8	29.1	39.4	39.4
+ Intangibles under Development	7.7	2.7	3.9	3.9
+ Non-current Investments	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	—	0.1	0.0	0.0
Non-current Financial Assets	0.0	0.1	0.0	0.0
+ Other Non-current Assets	25.0	1.9	0.3	0.3
Total Non-current Assets	157.7	167.4	159.3	159.3
Current Assets
+ Inventories	123.6	138.8	102.8	102.8
+ Trade Receivables	27.9	39.1	40.3	40.3
+ Cash & Cash Equivalents	0.9	2.6	0.7	0.7
+ Other Bank Balances	0.0	0.0	0.0	0.0
+ Short-term Loans	1.2	1.1	0.1	0.1
+ Other Current Financial Assets	4.7	5.5	3.2	3.2
Current Financial Assets	34.7	48.2	44.2	44.2
+ Other Current Assets	17.3	11.9	8.7	8.7
Total Current Assets	175.7	199.0	155.7	155.7
Total Assets	333.4	366.4	315.0	315.0
Equity
+ Equity Share Capital	15.8	15.8	15.8	15.8
+ Other Equity / Reserves	120.0	133.2	87.2	87.2
Equity — Owners of Parent	135.8	149.0	103.1	103.1
Total Equity	135.8	149.0	103.1	103.1
Liabilities
+ Borrowings — Non-current	13.4	9.2	8.6	8.6
+ Other Non-current Financial Liab	5.1	2.5	0.0	0.0
Non-current Financial Liabilities	18.5	11.7	8.6	8.6
+ Deferred Tax Liabilities	12.1	9.8	5.2	5.2
+ Other Non-current Liabilities	3.3	4.3	1.6	1.6
Non-current Liabilities	33.8	25.8	15.3	15.3
+ Borrowings — Current	74.6	71.9	96.9	96.9
+ Trade Payables	65.9	91.1	75.9	75.9
+ Other Current Financial Liab	13.9	12.5	7.3	7.3
Current Financial Liabilities	154.4	175.6	180.1	180.1
+ Provisions — Current	1.0	1.1	1.4	1.4
+ Current Tax Liabilities	0.0	0.9	—	—
+ Other Current Liabilities	8.4	13.9	15.1	15.1
Current Liabilities	163.8	191.6	196.6	196.6
Total Liabilities	197.6	217.4	211.9	211.9
Total Equity & Liabilities	333.4	366.4	315.0	315.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	7.3	12.1	12.1
+ Dues to Other Creditors — Current	—	83.9	63.8	63.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.